Renaissance Technologies - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 168 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,361
+87.5%
1,417,567
+46.5%
0.00%
+100.0%
Q1 2023$726
+84.7%
967,400
-9.3%
0.00%0.0%
Q4 2022$393
-99.9%
1,066,400
+6.9%
0.00%0.0%
Q3 2022$429,000
-53.8%
997,400
-16.3%
0.00%0.0%
Q2 2022$929,000
-48.7%
1,191,049
-15.2%
0.00%
-50.0%
Q1 2022$1,811,000
+71.8%
1,404,039
+69.1%
0.00%
+100.0%
Q4 2021$1,054,000
+1749.1%
830,249
+3101.0%
0.00%
Q3 2021$57,000
-93.4%
25,937
-88.8%
0.00%
-100.0%
Q2 2021$867,000
-84.0%
231,167
-86.1%
0.00%
-85.7%
Q1 2021$5,402,000
-33.4%
1,657,140
-30.3%
0.01%
-22.2%
Q4 2020$8,108,000
-41.1%
2,377,802
-29.5%
0.01%
-35.7%
Q3 2020$13,760,000
+35.6%
3,372,615
+12.3%
0.01%
+55.6%
Q2 2020$10,147,000
+92.9%
3,002,073
+33.0%
0.01%
+80.0%
Q1 2020$5,261,000
-48.4%
2,257,742
-19.5%
0.01%
-37.5%
Q4 2019$10,204,000
-55.5%
2,803,300
+1.4%
0.01%
-57.9%
Q3 2019$22,936,000
-2.3%
2,765,017
+1.4%
0.02%
-9.5%
Q2 2019$23,474,000
+29.8%
2,726,317
+61.1%
0.02%
+31.2%
Q1 2019$18,089,000
+106.8%
1,692,182
+69.3%
0.02%
+60.0%
Q4 2018$8,747,000
-68.4%
999,600
-39.4%
0.01%
-64.3%
Q3 2018$27,698,000
-83.1%
1,648,700
-81.9%
0.03%
-68.5%
Q2 2018$163,507,000
+82.1%
9,097,400
+63.0%
0.09%
-9.2%
Q1 2018$89,782,000
-23.3%
5,580,000
-9.7%
0.10%
-24.0%
Q4 2017$117,128,000
+25.0%
6,180,917
-7.2%
0.13%
+17.3%
Q3 2017$93,697,000
+107.1%
6,659,317
+9.7%
0.11%
+89.7%
Q2 2017$45,235,000
+22.5%
6,071,817
+6.9%
0.06%
+11.5%
Q1 2017$36,919,000
+61.0%
5,679,800
+9.7%
0.05%
+44.4%
Q4 2016$22,935,000
-11.4%
5,177,312
-6.6%
0.04%
-21.7%
Q3 2016$25,881,000
-13.6%
5,541,957
+21.6%
0.05%
-19.3%
Q2 2016$29,947,000
+42.5%
4,558,117
+38.0%
0.06%
+42.5%
Q1 2016$21,014,000
+34.5%
3,304,100
+27.5%
0.04%
+17.6%
Q4 2015$15,626,000
+47.3%
2,591,319
+46.1%
0.03%
+36.0%
Q3 2015$10,606,000
-13.2%
1,773,517
-0.7%
0.02%
-10.7%
Q2 2015$12,216,000
+44.7%
1,785,917
+28.4%
0.03%
+55.6%
Q1 2015$8,445,000
+391.3%
1,391,217
+461.0%
0.02%
+350.0%
Q4 2014$1,719,000
+13.7%
248,000
+33.4%
0.00%0.0%
Q2 2014$1,512,000
+12.6%
185,917
+8.5%
0.00%
+33.3%
Q1 2014$1,343,000
+118.4%
171,307
+146.4%
0.00%
+200.0%
Q4 2013$615,000
+508.9%
69,517
+478.5%
0.00%
Q3 2013$101,00012,0170.00%
Other shareholders

There were no reported owners of SPECTRUM PHARMACEUTICALS INC in Q3 2019.

NameSharesValueWeighting ↓
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders